Given that the two pathways most increased at the mRNA levels in FCMs compared to NFMs were the LXR and hepatic fibrosis pathways (Fig 2), we used immunohistochemistry to validate these findings in sections of subcutaneous sponges from ApoE null mice. The gene discussed is APOE; the disease is Hepatic fibrosis.